SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Xetra Frankfurt
Börse Xetra Frankfurt
ISIN US717081ER06
EUR
  • Pfizer
    Börse NYSE New York Stock Exchange
    ISIN US7170811035 WKN: 852009
    Symbol PFE
    USD
  • PFIZER INC
    Börse Börse Hamburg
    ISIN US717081ED10
    Symbol PFE
    EUR
  • Pfizer
    Börse Börse Stuttgart
    ISIN US717081DK61
    Symbol PFE
    EUR
  • Pfizer
    Börse Xetra Frankfurt
    ISIN US717081ER06
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse Düsseldorf
    ISIN XS1574158082
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse München
    ISIN US717081DZ31
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Gettex System der Börse München
    ISIN US717081ES88
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Tradegate System der Deutsche Börse AG (60%)
    ISIN US717081EQ23
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Quotrix System der Börse Düsseldorf
    ISIN US717081DE02
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse Frankfurt
    ISIN XS1574157357
    Symbol PFE
    EUR
  • Pfizer
    Börse Xetra Frankfurt
    ISIN US717081EY56
    EUR
  • Pfizer
    Börse Börse München
    ISIN US717081FA61
    EUR
  • Pfizer
    Börse SSE Stockholm Stock Exchange
    ISIN US717081EZ22
    Symbol PFE
    SEK
  • Pfizer
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US717081EK52
    Symbol PFE
    MXN
  • Pfizer
    Börse Bolsa de Comercio de Buenos Aires
    ISIN US717081DV27
    USD
  • Pfizer
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US717081DH33
    MXN
  • Pfizer
    Börse BUE
    ISIN US717081EV18
    USD
  • ISIN US717081EX73
    Symbol PFE
    EUR
  • Pfizer
    Börse OMXS
    ISIN US7170811035
    SEK
  • ISIN US717081EJ89
    EUR
  • PFIZER INC
    Börse SSE
    ISIN US717081EP40
ISIN US717081ER06
Symbol PFE
Währung EUR
Börse Xetra Frankfurt Zeitzone: Europe/Berlin
Firmenname Pfizer Inc
Marktkapitalisierung 197.500.079.920 (+- 10%)

Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:

204.882.624.512 oder 216.419.000.000 oder 171.198.615.249

Mitarbeiter 83.400 (+- 6%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

88.300 oder 78.500 Mitarbeiter

Anzahl Aktien 5.558.396.599
KGV 18.68 (+- 28%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

23.97 oder 13.4

EBITDA 19.320.000.512
PEGRatio 4.9741
Buchwert 11.744

Zahlte zuletzt am 06.05.2021 eine Dividende von 0,39  . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht

Analystenmeinungen

Übersicht

Letzte Communitymeinungen

Ein User hat Pfizer abonniert.

Aktionärsstruktur der Pfizer Inc

1.790 News & Informationen zur Pfizer Aktie

  • Birinyi Associates Inc Buys Lam Research Corp, Facebook Inc, Booking Holdings Inc, Sells Peloton Interactive Inc, Salesforce.com Inc, Tesla...
    gurufocus.com

    Birinyi Associates Inc Buys Lam Research Corp, Facebook Inc, Booking Holdings Inc, Sells Peloton Interactive Inc, Salesforce.com Inc, Tesla Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Novavax Is Not a Sure Thing, But It’s Getting Closer
    valuewalk.com

    Novavax Is Not a Sure Thing, But It’s Getting Closer

    Novavax (NASDAQ:NVAX) stock is on a bullish run after the company’s most recent earnings report. After gapping down 19% after issuing

  • What Drove Moderna Stock From $100 To Near $500?
    forbes.com

    What Drove Moderna Stock From $100 To Near $500?

    Moderna stock has rallied from around $104 per share at the end of 2020, to about $485 as of Monday, an increase of over 4.5x. This compares to the S&P 500 which is up by just about 20% over the same period. The first leg of the rally that happened through the first half of this year was relatively.

  • Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026
    markets.businessinsider.com

    Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026

    SAN FRANCISCO, Aug. 20, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research comp…

  • Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026
    prnewswire.com

    Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026

    /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…

  • Israeli doctors find severe COVID-19 breakthrough cases mostly in older, sicker patients By Reuters
    investing.com

    Israeli doctors find severe COVID-19 breakthrough cases mostly in older, sicker patients By Reuters

    Israeli doctors find severe COVID-19 breakthrough cases mostly in older, sicker patients

  • U.S. reviewing if Moderna shot tied to higher heart inflammation risk
    investing.com

    U.S. reviewing if Moderna shot tied to higher heart inflammation risk

    U.S. reviewing if Moderna shot tied to higher heart inflammation risk – Washington Post

  • Joaquin Duato To Replace Alex Gorsky As J&J CEO
    valuewalk.com

    Joaquin Duato To Replace Alex Gorsky As J&J CEO

    Joaquin Duato will be promoted from vice chairman of the company’s executive committee after working for the pharma giant for more than 30 years, and he will

  • Joaquin Duato To Replace Alex Gorsky As J&J CEO
    entrepreneur.com

    Joaquin Duato To Replace Alex Gorsky As J&J CEO

    Johnson & Johnson (NYSE:JNJ) has announced the appointment of Joaquin Duato as the company’s new CEO as of January 3. Alex Gorsky, who has been in…

  • Pfizer’s Global Covid-19 Vaccine Rollout Depends on Two Expert Staffers
    online.wsj.com

    Pfizer’s Global Covid-19 Vaccine Rollout Depends on Two Expert Staffers

    Vaccine makers like Pfizer are relying on key employees with expertise in biochemical engineering and pharmaceutical manufacturing to transfer the technology to contract manufacturers in order to scale up production of Covid-19 vaccines.

  • What you need to know about the coronavirus right now
    financialpost.com

    What you need to know about the coronavirus right now

    Here’s what you need to know about the coronavirus right now:

  • Analysis-Red tape, risk aversion clip wings of Merkel's innovation legacy By Reuters
    investing.com

    Analysis-Red tape, risk aversion clip wings of Merkel's innovation legacy By Reuters

    Analysis-Red tape, risk aversion clip wings of Merkel's innovation legacy

  • In a sports-crazed Arkansas town, football is a reason to get vaccinated By Reuters
    investing.com

    In a sports-crazed Arkansas town, football is a reason to get vaccinated By Reuters

    In a sports-crazed Arkansas town, football is a reason to get vaccinated

  • PM Naftali Bennett receives third COVID-19 shot as Israel extends booster campaign
    moneycontrol.com

    PM Naftali Bennett receives third COVID-19 shot as Israel extends booster campaign

    New cases in Israel have surged since Delta's emergence and Bennett, 49, has sought to avoid an economically painful national lockdown by ramping up third doses.

  • PM has third COVID-19 shot as Israel extends booster campaign
    financialpost.com

    PM has third COVID-19 shot as Israel extends booster campaign

    JERUSALEM — Israeli Prime Minister Naftali Bennett received a third shot of Pfizer/BioNtech’s COVID-19 vaccine on Friday, after Israel extended its booster…

  • Acting FDA Chief Janet Woodcock Ruled Out as Biden Nominee
    bloombergquint.com

    Acting FDA Chief Janet Woodcock Ruled Out as Biden Nominee

    (Bloomberg) — President Joe Biden’s administration has ruled out nominating Janet Woodcock as permanent head of the Food and Drug Administration, people familiar with the matter say, as the search continues for a leader during a crucial period for full approval of coronavirus vaccines.

  • South Africa Eases Age Restriction on Coronavirus Shots to 18+
    bloombergquint.com

    South Africa Eases Age Restriction on Coronavirus Shots to 18+

    (Bloomberg) — South Africa will make coronavirus vaccines available to all those aged 18 and over from Friday after the cabinet agreed to accelerate its inoculation drive amid a third wave of infections.

  • Should Investors Follow Private Equity into Life Sciences?
    gurufocus.com

    Should Investors Follow Private Equity into Life Sciences?

    GuruFocus Article or News written by Barry Cohen and the topic is about: Bain Capital has put about $4 billion into industry funds since 2017

  • Global Atopic Dermatitis Drugs Market Report 2021: Rising Incident of Food Allergies Intensifying Atopic Dermatitis - Forecast to 2026
    markets.businessinsider.com

    Global Atopic Dermatitis Drugs Market Report 2021: Rising Incident of Food Allergies Intensifying Atopic Dermatitis – Forecast to 2026

    DUBLIN, Aug. 19, 2021 /PRNewswire/ — The 'Global Atopic Dermatitis Drugs Market (2021-2026) by Drug Class, Route of Administration, Geography, Co…

  • U.S. administers 359.6 million doses of COVID-19 vaccines
    investing.com

    U.S. administers 359.6 million doses of COVID-19 vaccines

    U.S. administers 359.6 million doses of COVID-19 vaccines – CDC

  • U.S. prepares to administer 100 million booster shots as Biden tells Americans it will ‘help us end the pandemic faster’
    marketwatch.com

    U.S. prepares to administer 100 million booster shots as Biden tells Americans it will ‘help us end the pandemic faster’

    The Biden administration plans to administer 100 million COVID-19 booster shots over the fall and winter in a move that underscores the complexity of the…

  • Global Intranasal Drug Delivery Market Forecast to 2027: Burgeoning Geriatric Populace Spurs Growing Demand
    prnewswire.com

    Global Intranasal Drug Delivery Market Forecast to 2027: Burgeoning Geriatric Populace Spurs Growing Demand

    /PRNewswire/ — The

  • Global Intranasal Drug Delivery Market Forecast To 2027: Burgeoning Geriatric Populace Spurs Growing Demand
    thestreet.com

    Global Intranasal Drug Delivery Market Forecast To 2027: Burgeoning Geriatric Populace Spurs Growing Demand

    DUBLIN, Aug. 19, 2021 /PRNewswire/ — The

  • Cathie Wood’s ARK Invest Buys Over 150,000 Shares of This COVID-19 Vaccine Supplier – 24/7 Wall St.
    247wallst.com

    Cathie Wood’s ARK Invest Buys Over 150,000 Shares of This COVID-19 Vaccine Supplier – 24/7 Wall St.

    One of Cathie Wood's ARK Invest funds bought over 150,000 shares of Pfizer on August 18.

  • Smoking Cessation Aids Market to exceed US$ 64,032.30 million by 2028 - COVID-19 Impact and Global Analysis by The Insight Partners
    prnewswire.com

    Smoking Cessation Aids Market to exceed US$ 64,032.30 million by 2028 – COVID-19 Impact and Global Analysis by The Insight Partners

    /PRNewswire/ — According to our new research study on “Smoking Cessation Aids Market Forecast to 2028 – by Product, End User, and Geography,” the Smoking…

  • U.S. Degenerative Disc Disease Treatment Market to Surpass 3.958 Million patients by 2028, Says Coherent Market Insights (CMI)
    globenewswire.com

    U.S. Degenerative Disc Disease Treatment Market to Surpass 3.958 Million patients by 2028, Says Coherent Market Insights (CMI)

    SEATTLE, Aug. 19, 2021 (GLOBE NEWSWIRE) — U.S. Degenerative Disc Disease Treatment Market to Surpass 3.958 Million patients by 2028, Says Coherent…

  • Australia new cases hit record; jabs less effective against Delta
    businessmirror.com.ph

    Australia new cases hit record; jabs less effective against Delta

    Australia suffered its worst day since the start of the Covid-19 pandemic, with cases surpassing the record posted more than a year ago as an outbreak of the Delta variant spreads. New South Wales recorded 681 new cases, Premier Gladys Berejiklian told reporters on Thursday in Sydney, where stay-at-home orders…

  • As covid-19 boosters loom, Pfizer and Moderna expected to see billions more in sales
    livemint.com

    As covid-19 boosters loom, Pfizer and Moderna expected to see billions more in sales

    The spread of the Delta variant is increasing demand for messenger RNA vaccines and boosters, while the companies raise prices

  • Treasury yields fall as growth worries pressure stocks
    marketwatch.com

    Treasury yields fall as growth worries pressure stocks

    Treasury yields fall Thursday, pressured by worries about the spread of the delta variant of the coronavirus that causes COVID-19 on the economic outlook…

  • Will The Gains Continue For Johnson & Johnson Stock After A 7% Rise In A Month?
    forbes.com

    Will The Gains Continue For Johnson & Johnson Stock After A 7% Rise In A Month?

    The stock price of Johnson & Johnson (NYSE: JNJ) has seen a rise of over 7% over the last twenty-one trading days, and it is also up 15% year-to-date. Note that such a move for JNJ stock is uncommon, and it has occurred less than 90 times over the last 10 years…

  • Australia Suffers Worst Day; Singapore Eases Curbs: Virus Update
    bloombergquint.com

    Australia Suffers Worst Day; Singapore Eases Curbs: Virus Update

    (Bloomberg) — Singapore is easing pandemic restrictions, allowing more people to return to the office Thursday. The nation is also widening vaccine eligibility to include special pass holders such as those on training work permits.

    In the U.S.

  • Biden’s Booster Shot Push Raises Concerns Among Health Experts
    bloombergquint.com

    Biden’s Booster Shot Push Raises Concerns Among Health Experts

    (Bloomberg) — The White House’s plan to begin offering booster shots next month to almost all vaccinated U.S. adults is raising concerns among health experts that the administration is rushing ahead without enough data and regulatory oversight. 

    On Wednesday as expected, officials from the U.S.

  • Sydney vaccine rollout sped up as Australia's COVID-19 cases hit high By Reuters
    investing.com

    Sydney vaccine rollout sped up as Australia's COVID-19 cases hit high By Reuters

    Sydney vaccine rollout sped up as Australia's COVID-19 cases hit high

  • British study shows COVID-19 vaccine efficacy wanes under Delta By Reuters
    investing.com

    British study shows COVID-19 vaccine efficacy wanes under Delta By Reuters

    British study shows COVID-19 vaccine efficacy wanes under Delta

  • Gyon Technologies Capital Management, LP Buys Acuity Brands Inc, Mohawk Industries Inc, Marvell Technology Inc, Sells Amazon.com Inc,...
    gurufocus.com

    Gyon Technologies Capital Management, LP Buys Acuity Brands Inc, Mohawk Industries Inc, Marvell Technology Inc, Sells Amazon.com Inc, Micron Technology Inc, Ball Corp

    GuruFocus Article or News written by insider and the topic is about:

  • Anchor Capital Advisors Llc Buys CarGurus Inc, Royal Gold Inc, Clorox Co, Sells CDK Global Inc, Haemonetics Corp, Verizon Communications Inc
    gurufocus.com

    Anchor Capital Advisors Llc Buys CarGurus Inc, Royal Gold Inc, Clorox Co, Sells CDK Global Inc, Haemonetics Corp, Verizon Communications Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Northeast Financial Consultants Inc Buys Apple Inc, Pfizer Inc, Boeing Co, Sells United Parcel Service Inc, Albertsons Inc, Chart...
    gurufocus.com

    Northeast Financial Consultants Inc Buys Apple Inc, Pfizer Inc, Boeing Co, Sells United Parcel Service Inc, Albertsons Inc, Chart Industries Inc

    GuruFocus Article or News written by insider and the topic is about:

  • U.S. administers 358.6 million doses of COVID-19 vaccines
    investing.com

    U.S. administers 358.6 million doses of COVID-19 vaccines

    U.S. administers 358.6 million doses of COVID-19 vaccines – CDC

  • Delta variant threat: US to offer COVID-19 vaccine booster shots from Sept
    businesstoday.in

    Delta variant threat: US to offer COVID-19 vaccine booster shots from Sept

    The booster shots initially will be given primarily to healthcare workers, nursing home residents and older people, all of whom were among the first groups to be vaccinated in late 2020 and early 2021

  • 3 Biotech Penny Stocks With High Volume To Watch in August
    pennystocks.com

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Pfizer Aktie

Das Unternehmen Pfizer Inc aus USA beschäftigt 83.400 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.

Tochterunternehmen von Pfizer sind: Pfizer Ltd/India, PFIZER LTD., Pfizer Limited.

Das Unternehmen Pfizer Inc ist in mehr als 89 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Morningstar Durable Dividend ETF gewichtet Pfizer mit 5,94% im ETF.

Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Pfizer Anleihen auf einen Blick.

Entdecke die 6 ETFs in denen Pfizer Inc am höchsten gewichtet ist Insgesamt in 89 ETFs enthalten

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba